Skip to Content

Shalin J. Shah

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests


Uniting 4 a Cure            4/30/2011 - 7/14/2022

The road to Wellness

Major Goals: Support the initial expansion of this program to a second Regional Care Center (Sugar Land, Texas) and to support research that would investigate the effectiveness of these interventions in patients undergoing radiation therapy.


Office Address

The University of Texas MD Anderson Cancer Center
1327 Lake Pointe Parkway
Suite 100
Sugar Land, TX 77478
Phone: (281) 566-1802
Fax: (281) 566-1801

Education & Training

Degree-Granting Education

2002 Albert Einstein College of Medicine, Bronx, NY, MD, Medicine - with Distinction for Research in Radiation Oncology
1997 Cornell University, College of Agriculture and Life Sciences, Ithaca, NY, BS, Biometry and Statistics-with Distinction

Postgraduate Training

7/2007-6/2008 Clinical Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Thomas Buchholz
7/2002-6/2007 Clinical Residency, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, NY, Dr. Marnee Spierer
7/2002-6/2003 Clinical Rotations, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, NY, Dr. James Butler
7/2001-6/2002 Research Fellowship, Albert Einstein College of Medicine, Bronx, NY, Dr. Chandan Guhu

Board Certifications

2008 American Board of Radiology


Other Appointments/Responsibilities

Research Fellowship, Albert Einstein Summer Research Fellowship, Department of Infectious Diseases, Beth Israel Hospital, New York, NY, 6/1998-8/1998
International Clinical Oncology Fellowship, M.P. Shah Cancer Hospital, Amdavad, India, 5/1995-8/1995

Honors and Awards

2006-2007 Chief Resident, The University of Texas M.D. Anderson Cancer Center - Department of Radiation Oncology
2005-2006 ASCO International Mentorship Award
2003 Community Service Award, BJ Medical Alumni Association
2002 Distinction for Research in Radiation Oncology
2001 Albert Einstein Research Fellowship
1998 Albert Einstein Summer Research Award
1997 Dean's Award for Academic Excellence
1997 Golden Key National Honor Society
1997 Graduation with Distinction
1994 International Clinical Oncology Fellowship, Gujarat Cancer Society
1993-1997 Dean's list for the College of Agriculture and Life Sciences, Cornell University
1993 Faculty Award for Excellence in Biology
1993 Texaco Star Academic Challenge Scholarship
1992 Dartmouth Book Award

Professional Memberships

American Society for Therapeutic Radiology and Oncology
Member, 2002-present
American Society of Clinical Oncology
Member, 2002-present
Gilbert H. Fletcher Society
Member, 4/2011-present
Indo American Cancer Network, Houston, TX
Executive Board, 10/2012-present
Society for Integrative Oncology
Member, 7/2010-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Schwartz DL, Garden AS, Shah SJ, Chronowski G,Sejpal S, Rosenthal DI, Chen Y, Shang Y, Zhang L, Wong PF, Garcia JA, Kian Ang K, Dong L. Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial. Radiother Oncol 106(1):80-4, doi: 10.1016/j.radonc.2012., 2013 Jan, 1/2013. PMID: 23369744.
2. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Brandon G, Kupferman ME, Ang KK, Rosenthal DI. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 1(83(1)):204-9, 2012 May 1, 5/2012. e-Pub 10/2011. PMID: 22019242.
3. Mendoza TR, Gunn GB, Wang XS, Frank SJ, Beadle BM, Shah SJ, Lu C, Hanna EY, Cleeland CS, Rosenthal DI. Impact of sympton burden on survival in patients with head and neck cancer treated with definitive radiation therapy. Radiation Oncology 78(3 Supplement):S470-S471, 2010.
4. Dong, L, Chen YP, Lindberg ME, Garden AS, Rosenthal DI, Sejpal SV, Shah SJ, Morrison, WH, Ang KK, Schwartz DL. Interfractional movement of the larynx and oropharynx during radiotherapy. Radiation Oncology 75(3 Supplement 1):S16-17, 2009.
5. Schwartz D, Ang K, Chronowski G, Rosenthal DI, Sejpal SV, Shah SJ, Zhang Y, Garcia J, Garden A, Dong L. Prospective experience with CT-guided adaptive radiotherapy for head-and-neck cancer. Radiation Oncology 75(3 Supplement 1):S72, 2009.
6. Yaparpalvi R, Guha C, Danish A, Shah SJ, Kahan N, Minsky L, Engler M, and Kalnicki S. Comparison of inta-operative computer optimized and nomogram-bases total implant activities in prostate I-125 seed implants. Med Phys 32(6):1954-55, 2005, 2005.
7. Menethena A, Deb N, Oertel m, Grozdanov PN, Sandhu J, Shah SJ, Guha C, Shafritz DA, Dabeva MD. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stems Cells 22(6):1049-61, 2004, 2004.
8. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22(41):6408-23, 9/2003. PMID: 14508521.
9. Guha C, Shah SJ, Ghosh SS, Lee SW, Roy-Chowdhury N, Roy-Chowdhury J. Molecular therapies for viral hepatitis. BioDrugs 17(2):81-91, 2003. PMID: 12641487.


1. Shah S, Reed V, Arzu I. Nurse Navigators in EarlyCancer Cancer: A Randomized, Controlled Trial. Breast Diseases: A Year Book Quarterly 26(1):31-32, 2015.
2. Reed VK, Shah SJ, Schlembach PJ. pN0(i+) Breast Cancer: Treatment Patterns, Locoregional Recurrence and Survival Outcomes. Breast Diseases Quarterly 25(2):129-130, 2014.
3. Dudley DJ, Drake J, Quinlan J, et al (Univ of Texas Health Science Ctr at San Antonio). Beneficial Effects of a Combined Navigator/Promotora Approach for Hispanic Women Diagnosed with Breast Abnormalities. Breast Diseases A Year Book Quarterly 24(2), 7/2013.


1. Mukhopadhaya A, Mendecki J, Yamanouchi K, Shah SJ, Basu I, Alfieri A, Garg M, Kalnicki S, Guha C. Localized hyperthermia combined with intratumoral dendritic cell injection induces systemic antitumor immunity. Proc Amer Assoc Cancer Res 46:725, 2005.

Last updated: 10/12/2015